Duesseldorf (ots) - - Gerresheimer presents an extensive portfolio of containment solutions, drug delivery systems and digital therapy support - High-quality ready-to-fill solutions for biopharmaceuticals, cell and gene therapy - EcoDesign and environmentally friendly packaging options ensure greater sustainability Gerresheimer, an innovative system and solution ...
Vienna (ots) - The near 1.5 billion liters of fossil fuels used daily worldwide must be replaced by carbon-neutral fuels by 2050 if we are to achieve the climate goals. More than 1,000 experts at the 44th International Motor Symposium in Vienna discussed the global strategies required to achieve these targets. The potential for producing renewable energy is particularly great in regions such as North Africa, the Middle ...
Takeda Pharma Vertrieb GmbH & Co. KG
Zurich (ots/PRNewswire) - - If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. - Positive Opinion Based on Pivotal Study SHP643-301, Evaluating the Safety Profile and Pharmacokinetics (PK) of Lanadelumab, in Combination with ...
Berlin (ots) - The World Health Summit 2023 from October 15-17 in Berlin will bring together the most prominent names in global health from all sectors in all regions of the world. Speakers will include government ministers from over 10 countries, renowned scientists, and high-level representatives from the private ...
Leipzig Tourismus und Marketing GmbH
Heidelberger Druckmaschinen AG
Heidelberg (ots) - · Off to a good start: sales and EBITDA for first quarter up on previous year · Incoming orders stable: recovery in Asia but muted demand in other parts of the world · Strong growth areas: machines for digital label printing and packaging printing · Adjusted free cash flow: slightly better compared with previous year but negative overall · Financing structure: realigned in the medium term ...
Aachen, Germany and Tokyo, Japan (ots) - - The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines - The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and ...
